Veterinary Therapeutics Market - Global Outlook and Forecast 2022-2028

March 2022 | 66 pages | ID: V3311948EB4AEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Veterinary Therapeutics in Global, including the following market information:

Global Veterinary Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Veterinary Therapeutics market was valued at 30930 million in 2021 and is projected to reach US$ 39720 million by 2028, at a CAGR of 3.6% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Anti-inflammatory Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Veterinary Therapeutics include Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Eli Lilly and Company (Elanco Animal Health), Merck Animal Health, Sanofi (Merial Animal Health), Virbac and Vetoquinol S.A. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Veterinary Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Veterinary Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Veterinary Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Anti-inflammatory
• Parasiticides
• Others

Global Veterinary Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Veterinary Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Veterinary Clinics
• Drug Stores
• Others

Global Veterinary Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Veterinary Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Veterinary Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Veterinary Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bayer AG
• Boehringer Ingelheim GmbH
• Ceva Sante Animale
• Dechra Pharmaceuticals PLC
• Eli Lilly and Company (Elanco Animal Health)
• Merck Animal Health
• Sanofi (Merial Animal Health)
• Virbac
• Vetoquinol S.A.
• Zoetis, Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Veterinary Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Veterinary Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL VETERINARY THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Veterinary Therapeutics Market Size: 2021 VS 2028
2.2 Global Veterinary Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Veterinary Therapeutics Players in Global Market
3.2 Top Global Veterinary Therapeutics Companies Ranked by Revenue
3.3 Global Veterinary Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Veterinary Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Veterinary Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Veterinary Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Veterinary Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Veterinary Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Veterinary Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Anti-inflammatory
  4.1.3 Parasiticides
  4.1.4 Others
4.2 By Type - Global Veterinary Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Veterinary Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Veterinary Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Veterinary Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Veterinary Therapeutics Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Veterinary Clinics
  5.1.4 Drug Stores
  5.1.5 Others
5.2 By Application - Global Veterinary Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Veterinary Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Veterinary Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Veterinary Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Veterinary Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Veterinary Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Veterinary Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Veterinary Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Veterinary Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Veterinary Therapeutics Revenue, 2017-2028
  6.3.2 US Veterinary Therapeutics Market Size, 2017-2028
  6.3.3 Canada Veterinary Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Veterinary Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Veterinary Therapeutics Revenue, 2017-2028
  6.4.2 Germany Veterinary Therapeutics Market Size, 2017-2028
  6.4.3 France Veterinary Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Veterinary Therapeutics Market Size, 2017-2028
  6.4.5 Italy Veterinary Therapeutics Market Size, 2017-2028
  6.4.6 Russia Veterinary Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Veterinary Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Veterinary Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Veterinary Therapeutics Revenue, 2017-2028
  6.5.2 China Veterinary Therapeutics Market Size, 2017-2028
  6.5.3 Japan Veterinary Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Veterinary Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Veterinary Therapeutics Market Size, 2017-2028
  6.5.6 India Veterinary Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Veterinary Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Veterinary Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Veterinary Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Veterinary Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Veterinary Therapeutics Market Size, 2017-2028
  6.7.3 Israel Veterinary Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Veterinary Therapeutics Market Size, 2017-2028
  6.7.5 UAE Veterinary Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Bayer AG
  7.1.1 Bayer AG Corporate Summary
  7.1.2 Bayer AG Business Overview
  7.1.3 Bayer AG Veterinary Therapeutics Major Product Offerings
  7.1.4 Bayer AG Veterinary Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Bayer AG Key News
7.2 Boehringer Ingelheim GmbH
  7.2.1 Boehringer Ingelheim GmbH Corporate Summary
  7.2.2 Boehringer Ingelheim GmbH Business Overview
  7.2.3 Boehringer Ingelheim GmbH Veterinary Therapeutics Major Product Offerings
  7.2.4 Boehringer Ingelheim GmbH Veterinary Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Boehringer Ingelheim GmbH Key News
7.3 Ceva Sante Animale
  7.3.1 Ceva Sante Animale Corporate Summary
  7.3.2 Ceva Sante Animale Business Overview
  7.3.3 Ceva Sante Animale Veterinary Therapeutics Major Product Offerings
  7.3.4 Ceva Sante Animale Veterinary Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Ceva Sante Animale Key News
7.4 Dechra Pharmaceuticals PLC
  7.4.1 Dechra Pharmaceuticals PLC Corporate Summary
  7.4.2 Dechra Pharmaceuticals PLC Business Overview
  7.4.3 Dechra Pharmaceuticals PLC Veterinary Therapeutics Major Product Offerings
  7.4.4 Dechra Pharmaceuticals PLC Veterinary Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Dechra Pharmaceuticals PLC Key News
7.5 Eli Lilly and Company (Elanco Animal Health)
  7.5.1 Eli Lilly and Company (Elanco Animal Health) Corporate Summary
  7.5.2 Eli Lilly and Company (Elanco Animal Health) Business Overview
  7.5.3 Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Major Product Offerings
  7.5.4 Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Eli Lilly and Company (Elanco Animal Health) Key News
7.6 Merck Animal Health
  7.6.1 Merck Animal Health Corporate Summary
  7.6.2 Merck Animal Health Business Overview
  7.6.3 Merck Animal Health Veterinary Therapeutics Major Product Offerings
  7.6.4 Merck Animal Health Veterinary Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Merck Animal Health Key News
7.7 Sanofi (Merial Animal Health)
  7.7.1 Sanofi (Merial Animal Health) Corporate Summary
  7.7.2 Sanofi (Merial Animal Health) Business Overview
  7.7.3 Sanofi (Merial Animal Health) Veterinary Therapeutics Major Product Offerings
  7.7.4 Sanofi (Merial Animal Health) Veterinary Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Sanofi (Merial Animal Health) Key News
7.8 Virbac
  7.8.1 Virbac Corporate Summary
  7.8.2 Virbac Business Overview
  7.8.3 Virbac Veterinary Therapeutics Major Product Offerings
  7.8.4 Virbac Veterinary Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Virbac Key News
7.9 Vetoquinol S.A.
  7.9.1 Vetoquinol S.A. Corporate Summary
  7.9.2 Vetoquinol S.A. Business Overview
  7.9.3 Vetoquinol S.A. Veterinary Therapeutics Major Product Offerings
  7.9.4 Vetoquinol S.A. Veterinary Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 Vetoquinol S.A. Key News
7.10 Zoetis, Inc.
  7.10.1 Zoetis, Inc. Corporate Summary
  7.10.2 Zoetis, Inc. Business Overview
  7.10.3 Zoetis, Inc. Veterinary Therapeutics Major Product Offerings
  7.10.4 Zoetis, Inc. Veterinary Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 Zoetis, Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Veterinary Therapeutics Market Opportunities & Trends in Global Market
Table 2. Veterinary Therapeutics Market Drivers in Global Market
Table 3. Veterinary Therapeutics Market Restraints in Global Market
Table 4. Key Players of Veterinary Therapeutics in Global Market
Table 5. Top Veterinary Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Veterinary Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Veterinary Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Veterinary Therapeutics Product Type
Table 9. List of Global Tier 1 Veterinary Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Veterinary Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Veterinary Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Veterinary Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Veterinary Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Veterinary Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Veterinary Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Veterinary Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Veterinary Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Veterinary Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Veterinary Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Veterinary Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Veterinary Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Veterinary Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Veterinary Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Veterinary Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Veterinary Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Veterinary Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Veterinary Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Veterinary Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Veterinary Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Bayer AG Corporate Summary
Table 31. Bayer AG Veterinary Therapeutics Product Offerings
Table 32. Bayer AG Veterinary Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Boehringer Ingelheim GmbH Corporate Summary
Table 34. Boehringer Ingelheim GmbH Veterinary Therapeutics Product Offerings
Table 35. Boehringer Ingelheim GmbH Veterinary Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Ceva Sante Animale Corporate Summary
Table 37. Ceva Sante Animale Veterinary Therapeutics Product Offerings
Table 38. Ceva Sante Animale Veterinary Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Dechra Pharmaceuticals PLC Corporate Summary
Table 40. Dechra Pharmaceuticals PLC Veterinary Therapeutics Product Offerings
Table 41. Dechra Pharmaceuticals PLC Veterinary Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Eli Lilly and Company (Elanco Animal Health) Corporate Summary
Table 43. Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Product Offerings
Table 44. Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Merck Animal Health Corporate Summary
Table 46. Merck Animal Health Veterinary Therapeutics Product Offerings
Table 47. Merck Animal Health Veterinary Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Sanofi (Merial Animal Health) Corporate Summary
Table 49. Sanofi (Merial Animal Health) Veterinary Therapeutics Product Offerings
Table 50. Sanofi (Merial Animal Health) Veterinary Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Virbac Corporate Summary
Table 52. Virbac Veterinary Therapeutics Product Offerings
Table 53. Virbac Veterinary Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Vetoquinol S.A. Corporate Summary
Table 55. Vetoquinol S.A. Veterinary Therapeutics Product Offerings
Table 56. Vetoquinol S.A. Veterinary Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Zoetis, Inc. Corporate Summary
Table 58. Zoetis, Inc. Veterinary Therapeutics Product Offerings
Table 59. Zoetis, Inc. Veterinary Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Veterinary Therapeutics Segment by Type in 2021
Figure 2. Veterinary Therapeutics Segment by Application in 2021
Figure 3. Global Veterinary Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Veterinary Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Veterinary Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Veterinary Therapeutics Revenue in 2021
Figure 8. By Type - Global Veterinary Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Veterinary Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Veterinary Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Veterinary Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Veterinary Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Veterinary Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Veterinary Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Veterinary Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Veterinary Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Veterinary Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Veterinary Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Veterinary Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Veterinary Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Veterinary Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Veterinary Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Veterinary Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Veterinary Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Veterinary Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Veterinary Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Veterinary Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Veterinary Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Veterinary Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Veterinary Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Veterinary Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Veterinary Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Veterinary Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Veterinary Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Veterinary Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Veterinary Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Bayer AG Veterinary Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Boehringer Ingelheim GmbH Veterinary Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Ceva Sante Animale Veterinary Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Dechra Pharmaceuticals PLC Veterinary Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Merck Animal Health Veterinary Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Sanofi (Merial Animal Health) Veterinary Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Virbac Veterinary Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Vetoquinol S.A. Veterinary Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Zoetis, Inc. Veterinary Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)